Method development and validation for Cabotegravir and Rilpivirine by using HPLC and its degradants are characterized by LCMS and FTIR

Abstract Background Using a Symmetry C18 (4.6 × 150 mm, 3.5) column, a high-performance liquid chromatographic method for quantification of Rilpivirine and Cabotegravir in active pharmaceutical ingredients was developed and validated. The mobile phase is made up of buffer, acetonitrile, and 0.1 perc...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Anuradha Vejendla, Subrahmanyam Talari, Raju Moturu, S. N. Murthy Boddapati, A. Emmanuel Kola
Format: article
Langue:EN
Publié: SpringerOpen 2021
Sujets:
Accès en ligne:https://doaj.org/article/bb740d18053343ea90a656ec5ff22414
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!